Investors Research Corp’s Sanofi SNY Stock Holding History

Investors Research Corp’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$703K	Sell	16,468 -525	-3%	-$23.5K	0.13%	141
2026 Q1	$819K	Buy	16,993 +16,725	+6,241%	+$780K	0.16%	121
2025 Q4	$13K	Hold	268	–	–	﹤0.01%	598
2025 Q3	$12.7K	Hold	268	–	–	﹤0.01%	615
2025 Q2	$12.9K	Hold	268	–	–	﹤0.01%	637
2025 Q1	$14.9K	Buy	+268	New	+$14.5K	﹤0.01%	633
2024 Q3	–	Sell	-11,868	Closed	-$576K	–	1043
2024 Q2	$576K	Hold	11,868	–	–	0.13%	184
2024 Q1	$577K	Sell	11,868 -850	-7%	-$41.5K	0.13%	185
2023 Q4	$632K	Hold	12,718	–	–	0.15%	174
2023 Q3	$682K	Sell	12,718 -850	-6%	-$45.3K	0.18%	159
2023 Q2	$731K	Sell	13,568 -13,866	-51%	-$746K	0.18%	150
2023 Q1	$1.49M	Sell	27,434 -250	-0.9%	-$12.2K	0.39%	47
2022 Q4	$1.34M	Sell	27,684 -5	-0%	-$219	0.36%	60
2022 Q3	$1.05M	Buy	27,689 +24	+0.1%	+$1.07K	0.32%	69
2022 Q2	$1.38M	Sell	27,665 -250	-0.9%	-$13.3K	0.42%	49
2022 Q1	$1.43M	Hold	27,915	–	–	0.4%	57
2021 Q4	$1.4M	Hold	27,915	–	–	0.42%	64
2021 Q3	$1.35M	Hold	27,915	–	–	0.45%	61
2021 Q2	$1.47M	Hold	27,915	–	–	0.51%	55
2021 Q1	$1.38M	Sell	27,915 -375	-1%	-$18K	0.52%	39
2020 Q4	$1.38M	Sell	28,290 -125	-0.4%	-$6.17K	0.54%	26
2020 Q3	$1.43M	Sell	28,415 -500	-2%	-$25.7K	0.69%	18
2020 Q2	$1.48M	Sell	28,915 -250	-0.9%	-$12.2K	0.74%	15
2020 Q1	$1.27M	Sell	29,165 -725	-2%	-$34.7K	0.8%	11
2019 Q4	$1.5M	Hold	29,890	–	–	0.69%	11
2019 Q3	$1.39M	Sell	29,890 -225	-0.7%	-$9.7K	0.7%	11
2019 Q2	$1.3M	Buy	30,115 +25	+0.1%	+$1.06K	0.68%	12
2019 Q1	$1.33M	Sell	30,090 -250	-0.8%	-$10.7K	0.71%	13
2018 Q4	$1.32M	Buy	30,340 +300	+1%	+$13.2K	0.92%	8
2018 Q3	$1.34M	Sell	30,040 -768	-2%	-$32.8K	0.77%	17
2018 Q2	$1.23M	Buy	30,808 +75	+0.2%	+$2.95K	0.72%	19
2018 Q1	$1.23M	Buy	30,733 +9,275	+43%	+$386K	0.75%	18
2017 Q4	$923K	Buy	+21,458	New	+$989K	0.57%	43

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Investors Research Corp's SNY Position: Q2 2026 in Review

Investors Research Corp reduced its Sanofi (SNY) stake by 3.1% in Q2 2026, selling an estimated $23.5K and leaving 16,468 shares worth $703K. The position accounts for 0.13% of the portfolio, ranked #141.

Investors Research Corp first reported a position in SNY in Q4 2017 and has held it in 33 quarters since. The position peaked at $1.5M in Q4 2019. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Investors Research Corp held 16,468 shares of Sanofi worth $703K as of Q2 2026.
Investors Research Corp sold 525 Sanofi shares in Q2 2026, an estimated $23.5K.
Sanofi made up 0.13% of Investors Research Corp's portfolio in Q2 2026, its #141 holding.
Investors Research Corp first reported a position in Sanofi in Q4 2017 and has held it in 33 quarters since.
Investors Research Corp's Sanofi position peaked at $1.5M in Q4 2019.
716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Investors Research Corp's 13F filing for Q2 2026, filed 10 Jul 2026.